From: Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia
Age groups
Prevalence of CHEK2 I157T
<51
15% (3/20)
51-60
5.4% (2/37)
61-70
8.9% (7/79)
>70
12.1% (12/99)
total
10.2% (24/235)*